This important issue of Medical Clinics provides essential updates in heart failure. The following topics are covered: epidemiology, pathophysiology, and general approach for heart failure; symptoms, signs, diagnostic studies, and prognostic significance of systolic versus diastolic heart failure; the appropriate use of biomarkers; oral versus intravenous diuretic therapy; guideline-based therapy including RAAS blockade, beta-blockade, and aldosterone antagonist, appropriate use of AICD and biventricular pacing; role of ventricular assist device; pathophysiological consideration and management approaches in acute decompensated heart failure; pathophysiology and current approaches to cardiorenal syndrome; heart failure with other comorbidities including diabetes, obesity, anemia, and cancer; heart failure and atrial fibrillation; and the role of disease management strategies in heart failure.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Forthcoming Issues - p. 4 5. CME Accreditation Page and Author Disclosure - p. 5 6. Contributors - p. 6 7. Preface - p. 7 8. Infectious Disease Emergencies - p. 8 9. Role of Molecular Diagnostics in the Management of Infectious Disease Emergencies - p. 26 10. Choosing Optimal Antimicrobial Therapies - p. 32 11. Endocrine and Metabolic Changes During Sepsis - p. 40 12. Head and Neck Emergencies - p. 47 13. Pulmonary Emergencies - p. 58 14. Cardiac Emergencies - p. 69 15. Intra-abdominal and Pelvic Emergencies - p. 81 16. Necrotizing Soft-Tissue Infections - p. 92 17. Sepsis Syndrome, Bloodstream Infections, and Device-Related Infections - p. 98 18. Infectious Disease Emergencies in Returning Travelers - p. 109 19. Index - p. 126
This important issue of Medical Clinics provides essential updates in heart failure. The following topics are covered: epidemiology, pathophysiology, and general approach for heart failure; symptoms, signs, diagnostic studies, and prognostic significance of systolic versus diastolic heart failure; the appropriate use of biomarkers; oral versus intravenous diuretic therapy; guideline-based therapy including RAAS blockade, beta-blockade, and aldosterone antagonist, appropriate use of AICD and biventricular pacing; role of ventricular assist device; pathophysiological consideration and management approaches in acute decompensated heart failure; pathophysiology and current approaches to cardiorenal syndrome; heart failure with other comorbidities including diabetes, obesity, anemia, and cancer; heart failure and atrial fibrillation; and the role of disease management strategies in heart failure.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Forthcoming Issues - p. 4 5. CME Accreditation Page and Author Disclosure - p. 5 6. Contributors - p. 6 7. Preface - p. 7 8. Infectious Disease Emergencies - p. 8 9. Role of Molecular Diagnostics in the Management of Infectious Disease Emergencies - p. 26 10. Choosing Optimal Antimicrobial Therapies - p. 32 11. Endocrine and Metabolic Changes During Sepsis - p. 40 12. Head and Neck Emergencies - p. 47 13. Pulmonary Emergencies - p. 58 14. Cardiac Emergencies - p. 69 15. Intra-abdominal and Pelvic Emergencies - p. 81 16. Necrotizing Soft-Tissue Infections - p. 92 17. Sepsis Syndrome, Bloodstream Infections, and Device-Related Infections - p. 98 18. Infectious Disease Emergencies in Returning Travelers - p. 109 19. Index - p. 126
